期刊文献+

尿酸水平和补体激活在IgA肾病进展中的临床意义 被引量:1

The clinical significance of uric acid and complement activation in the progression of IgA Nephropathy
下载PDF
导出
摘要 目的调查临床的一般资料(年龄、性别)和实验室参数(血清尿酸,血清补体)作为标记IgA肾病(IgAN)患者进展的可靠性。方法总共纳入111例IgAN患者,随访期均>1年或达到终末期肾脏病,通过比较患者研究资料进行统计分析。结果所有患者平均随访期为(33±29)个月,其中37例(33.3%)患者发展到终末期肾脏病,结果表明,血清尿酸和补体C3/C4染色在e GFR>30 m L/(min·1.73 m2)患者中表达差异具有统计学意义(P<0.05)。结论高尿酸血症和补体沉积是IgAN进展的独立危险因素。 Objective To investigate the utility of clinical[age,gender]and laboratory parameters[eGFR,serum levels of uric acid,albumin]and pattern of staining for C3,as progression markers in patients with IgA Nephropathy(IgAN).Methods A total of111IgAN patients with a follow-up period>1year or who reached kidney failure[GFR category G5chronic kidney disease(CKD)]<1year were investigated.Results Mean follow-up period was(33±29)months.Thirty-seven(33.3%)patients progressed to kidney failure.In multivariate analysis,Serum uric acid level was associated independently with T score in patients with eGFR>eGFR>30mL/(min·1.73m2)(P<0.05).Conclusion Hyperuricemia and the deposition of C3are independent risk factors for IgAN progression.
作者 孙娜 SUN Na(Department of Nephrology,Tianjin First Center Hospital. Tianjin 300192, China)
出处 《中国处方药》 2017年第8期105-106,共2页 Journal of China Prescription Drug
关键词 IGA肾病 尿酸水平 补体 IgA Nephropathy Uric acid Complement
  • 相关文献

参考文献6

二级参考文献79

  • 1王金泉,刘志红,周虹,俞雨生,陈惠萍,唐政,黎磊石.补体膜攻击复合物和CD59在不同免疫病理类型IgA肾病发病机理中的作用[J].肾脏病与透析肾移植杂志,1996,5(4):23-27. 被引量:5
  • 2唐蓉,杜胜华,刘华锋.白介素18对肾小管上皮细胞分泌FN、Ⅰ型胶原的影响[J].中国现代医学杂志,2006,16(6):836-839. 被引量:4
  • 3王晓非,刘海娜,蒋莉,张榕,张晓莉,郭韵,段红梅.狼疮肾炎患者血中巨噬细胞衍生趋化因子和IL-18水平的变化及意义[J].细胞与分子免疫学杂志,2006,22(6):767-768. 被引量:5
  • 4Liu E,Morimoto M,Kitajima S,et al.Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions[J].J Am Soc Ncphrol,2007,18(7):2094-2104. 被引量:1
  • 5Eremina V,Sood M,Haigh J,et al.Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases[J].J Clin Invest,2003,111(5):707-716. 被引量:1
  • 6Kang DH,Anderson S,Kim YG,et al.Impaired angiogenesis in the aging kidney;va6cnlar endothelial growth factor and thrombespondin-1 in renal disesase[J].Am J Kidney Kis,2001,37(3):601-611. 被引量:1
  • 7Kikuchi Y,Imakiire T,Yamada M,et al.Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats[J].Nephrel Dial Transplant,2005,20(8):1573-1581. 被引量:1
  • 8Kochiadakis GE,Marketou ME,Panutsopulos D,et al.Vascular endothelial growth factor protein levels and gene expression in peripheral monacytes after stenting:a randomized comparative study of sirolimus:eluting and bare metal stents[J].Eur Heart J,2008,29(6):733-740. 被引量:1
  • 9Ostendod T,Kunter U,Eitner F,et al.VEGF(165)mediates glomerular endothelial repair[J].J Clin Invest,1999,104(7):913-923. 被引量:1
  • 10Cooper ME,Vranes D,Youssef S,et al.Increased renal expression of vascular endothelial growth factor(VEGF)and its receptor VEG-FR-2 in experimental diabetes[J].Diabetes,1999,48(11):2229-2239. 被引量:1

共引文献36

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部